183 related articles for article (PubMed ID: 21702043)
1. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer.
Zuzga DS; Pelta-Heller J; Li P; Bombonati A; Waldman SA; Pitari GM
Int J Cancer; 2012 Jun; 130(11):2539-48. PubMed ID: 21702043
[TBL] [Abstract][Full Text] [Related]
2. Differential Ser phosphorylation of vasodilator-stimulated phosphoprotein regulates colon tumor formation and growth.
Ali M; Zuzga DS; Pitari GM
Life Sci; 2021 Jan; 264():118671. PubMed ID: 33129878
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
Holt AW; Martin DN; Shaver PR; Adderley SP; Stone JD; Joshi CN; Francisco JT; Lust RM; Weidner DA; Shewchuk BM; Tulis DA
Cell Signal; 2016 Sep; 28(9):1364-1379. PubMed ID: 27302407
[TBL] [Abstract][Full Text] [Related]
4. Serine phosphorylation of vasodilator-stimulated phosphoprotein (VASP) regulates colon cancer cell survival and apoptosis.
Ali M; Rogers LK; Pitari GM
Life Sci; 2015 Feb; 123():1-8. PubMed ID: 25543053
[TBL] [Abstract][Full Text] [Related]
5. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells.
Wang X; Pluznick JL; Settles DC; Sansom SC
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1768-76. PubMed ID: 17913834
[TBL] [Abstract][Full Text] [Related]
6. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239.
Lindsay SL; Ramsey S; Aitchison M; Renné T; Evans TJ
J Cell Sci; 2007 Sep; 120(Pt 17):3011-21. PubMed ID: 17684063
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
[TBL] [Abstract][Full Text] [Related]
8. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.
Deguchi A; Soh JW; Li H; Pamukcu R; Thompson WJ; Weinstein IB
Mol Cancer Ther; 2002 Aug; 1(10):803-9. PubMed ID: 12492113
[TBL] [Abstract][Full Text] [Related]
10. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
Sudo T; Ito H; Kimura Y
Platelets; 2003 Sep; 14(6):381-90. PubMed ID: 14602552
[TBL] [Abstract][Full Text] [Related]
12. The role of vasodilator-stimulated phosphoprotein in podocyte functioning.
Rachubik P; Piwkowska A
Cell Biol Int; 2019 Oct; 43(10):1092-1101. PubMed ID: 30968998
[TBL] [Abstract][Full Text] [Related]
13. The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets.
Becker EM; Schmidt P; Schramm M; Schröder H; Walter U; Hoenicka M; Gerzer R; Stasch JP
J Cardiovasc Pharmacol; 2000 Mar; 35(3):390-7. PubMed ID: 10710123
[TBL] [Abstract][Full Text] [Related]
14. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
[TBL] [Abstract][Full Text] [Related]
15. Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation.
Zhuang S; Nguyen GT; Chen Y; Gudi T; Eigenthaler M; Jarchau T; Walter U; Boss GR; Pilz RB
J Biol Chem; 2004 Mar; 279(11):10397-407. PubMed ID: 14679200
[TBL] [Abstract][Full Text] [Related]
16. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
17. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody.
Smolenski A; Bachmann C; Reinhard K; Hönig-Liedl P; Jarchau T; Hoschuetzky H; Walter U
J Biol Chem; 1998 Aug; 273(32):20029-35. PubMed ID: 9685341
[TBL] [Abstract][Full Text] [Related]
18. The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading.
Lawrence DW; Pryzwansky KB
J Immunol; 2001 May; 166(9):5550-6. PubMed ID: 11313394
[TBL] [Abstract][Full Text] [Related]
19. VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen.
Defawe OD; Kim S; Chen L; Huang D; Kenagy RD; Renné T; Walter U; Daum G; Clowes AW
J Cell Physiol; 2010 Jan; 222(1):230-7. PubMed ID: 19798690
[TBL] [Abstract][Full Text] [Related]
20. Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239.
Tao Y; Gu YJ; Cao ZH; Bian XJ; Lan T; Sang JR; Jiang L; Wang Y; Qian H; Chen YC
Oncol Lett; 2012 Nov; 4(5):1104-1108. PubMed ID: 23162660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
